Parliament Workbench
Data: Official Report to 19 Nov 2026

Official Report · Committee

Continued Petitions

Hidradenitis Suppurativa (Specialist Support) (PE1682)

Thursday 27 June 2019 Public Petitions Committee About 10:30 Petitions 10 contributions · 4 speakers

Speakers

Choose an MSP to read only their contributions

The record

10 contributions
Johann Lamont Lab The Convener · Glasgow
link

The next petition is PE1682 by James Jamieson, which is on access to specialist support for hidradenitis suppurativa sufferers. The petition calls for a specialist clinic to be established in Scotland, as access to specialist support is currently provided only through referral to a clinic in England.

When we first considered the petition in May 2018, we noted concerns about a lack of awareness among general practitioners about the condition. The submissions from AbbVie Ltd and the Hidradenitis Suppurativa Trust agree that more needs to be done on the issue. AbbVie also considers that the development of a Scottish intercollegiate guidelines network guideline would improve referral pathways and ensure that patients can access the right care and treatment. The Scottish Government advises that anyone can suggest a guideline topic, and the process for doing that is set out in its submission.

The core of the petition is about the provision of specialist services. AbbVie and the Hidradenitis Suppurativa Trust consider that having a dedicated service for patients to access in Scotland would reduce stress and delays. The Government appears to suggest that the prevalence of HS is equivalent to more than 500 patients in a one-year period and therefore is not sufficiently rare or unpredictable to require the establishment of a specialist service. I am not quite sure what point is being made. It has said that there are more than 500 patients and that that number is too many for a specialist service, but the petitioner has said that there is no specialist service because there are few people with the condition.

Members will recall that Rona Mackay, who was previously a committee member, and I met the petitioner. The petitioner was frustrated about the condition not being understood or diagnosed early and the consequence of that for those who have the condition. It is as though the matter has fallen between two stools. As I said, I am quite confused about what point the Government is making.

Do members have any comments or suggestions for action?

Rachael Hamilton Con Ettrick, Roxburgh and Berwickshire
link

Regardless of the numbers, the petitioner makes the point that the

“prognosis for sufferers is very poor”

and that HS can severely impact their lives

“not just from the physical pain ... but also for their ... wellbeing.”

I was really struck by AbbVie’s submission, which highlights that the

“NHS has developed a digital dermatology resource”

and that the inclusion of HS in that resource

“would ... raise awareness of the condition”.

That would be an important step, and I wonder whether we could bring that to the Government’s attention.

Johann Lamont Lab The Convener · Glasgow
link

I think that we could agree to that action. Are there any other comments?

Brian Whittle Con South Scotland
link

We would certainly want a response from the petitioner on the Government’s response.

Johann Lamont Lab The Convener · Glasgow
link

Yes, we should ask for that. It would probably be worth while writing to the national health service boards, to ask how they identify what services they should provide for HS patients and how they deliver those services. I feel that we are not getting to the heart of the petitioner’s concern, which is that his condition is not really understood.

Johann Lamont Lab The Convener · Glasgow
link

No. The argument is about prevalence and at what point specialist services should be provided, but raising awareness about the condition is important.

Is there anything else that we could do?

Angus MacDonald SNP Falkirk East
link

The AbbVie submission refers to

“the NORSE clinic in the Midlands”.

We could write to that clinic to get its views on the action that the petition calls for and the referral pathways for HS.

Johann Lamont Lab The Convener · Glasgow
link

All those suggestions are very useful. Do members agree to take that action?

Members indicated agreement.

Johann Lamont Lab The Convener · Glasgow
link

Of course, we encourage the petitioner, if he feels able to do so, to respond to the submissions received to date, as we would be interested in hearing his views.

We will come back to the issue once we have received responses to our queries. I thank the petitioner for bringing the issue to our attention.

  1. 09:00 Decision on Taking Business in Private Procedure · 2
  2. 09:00 New Petition Petitions · 14
  3. 09:00 Continued Petitions Petitions · 1
  4. 09:00 Continued Petitions Petitions · 95
  5. 09:45 Continued Petitions Petitions · 5
  6. 09:45 Continued Petitions Petitions · 6
  7. 10:15 Continued Petitions Petitions · 5
  8. 10:15 Continued Petitions Petitions · 4
  9. 10:15 Continued Petitions Petitions · 12
  10. 10:30 Continued Petitions Petitions · 4
  11. 10:30 Continued Petitions Petitions · 14
  12. 10:30 Continued Petitions Petitions · 10
  13. 10:45 Continued Petitions Petitions · 9
  14. 10:45 Continued Petitions Petitions · 5
  15. 10:45 Continued Petitions Petitions · 50

The type of each item (debate, statement, questions, members’ business and so on) and the times shown are worked out by this site from headings, the chair’s opening words and the Official Report’s running timestamps. They are not the Parliament’s own classification. Text: the Scottish Parliament Official Report.